Updated on 14 August 2014
Mr Olivier Loeillot will take charge of commercial activities in the Asian market for GE Healthcare Life Science
Singapore: GE Healthcare Life Sciences has appointed Mr Olivier Loeillot as general manager, Asia Commercial for BioProcess segment.
In this role, Mr Loeillot will be responsible for overseeing commercial activities in the Asian market for GE Healthcare Life Science's BioProcess business, which provides start-to-finish technologies and services for the biopharmaceutical and vaccine manufacturing industry.
Mr Loeillot now reports to Mr Emmanuel Ligner, GM Global Commercial BioProcess, and is based in Singapore. He takes on this responsibility in addition to his role as GM Enterprise Solutions.
In September 2013, biopharmaceutical process development and manufacturing services provider JHL Biotech announced that the first of GE's innovative KUBioTM modular facilities for monoclonal antibody production would be built at its site in Wuhan, China and then, in December 2013, that GE's FlexFactory Biomanufacturing Platform had been successfully installed in its Taiwan facility.
Mr Ligner said, "The biopharmaceutical sector in Asia is seeing a lot of rapid growth and we are delighted that Olivier is heading up our efforts in this dynamic region. Olivier's extensive experience in biopharmaceutical manufacturing will strengthen significantly our ability to serve our customers there."
Mr Loeillot commented, "I'm looking forward to building on our existing relationships in the region. The deeper understanding gained from those interactions, combined with the solid foundation created by our Singapore and Shanghai Fast Trak Training Centres, will enable us to tailor our comprehensive offering according to the needs of the life sciences industry locally."